WHO ICTRP trial
study to examine long-term immunogenicity and safety of VaxiRab N (Rabies…
CTRI/2025/06/088886 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2025/06/088886 |
|---|---|
| Public title | study to examine long-term immunogenicity and safety of VaxiRab N (Rabies vaccine) in patients with animal bites |
| Scientific title | A prospective, randomized, single-blind, parallel, active-controlled, multicentre, phase IV clinical study to evaluate the long-term immunogenicity and safety of VaxiRab N compared to a WHO prequalified rabies vaccine in animal bite cases - NIL |
| Primary sponsor | Zydus Lifesciences Limited |
| Secondary sponsors | Cliantha Research limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: W54- Contact with dog Health Condition 2: W53- Contact with rodent |
| Interventions | Intervention1: VaxiRab N : 1. Participants enrolled to receive the vaccine via the IM route will receive 5 doses of the allotted vaccine on days 0 (visit 1), 3 (visit 2), 7 (visit 3), 14 (visit 4), and 28 (visit 5). Participants will be… |
| Registration date | Jun 16, 2025 |
| Target size | 476 |
| Secondary IDs | Protocol No.: VAXI.24.001 Version: 01 Date: 25 Sep 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: